These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 20507873)
1. Effects of angiotensin receptor blockade on atrial electrical remodelling and the 'second factor' in a goat burst-paced model of atrial fibrillation. Hall MC; Kirubakaran S; Choudhury R; Abidin N; Peters NS; Garratt CJ J Renin Angiotensin Aldosterone Syst; 2010 Dec; 11(4):222-33. PubMed ID: 20507873 [TBL] [Abstract][Full Text] [Related]
2. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Nakashima H; Kumagai K; Urata H; Gondo N; Ideishi M; Arakawa K Circulation; 2000 Jun; 101(22):2612-7. PubMed ID: 10840013 [TBL] [Abstract][Full Text] [Related]
3. Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation. Kumagai K; Nakashima H; Urata H; Gondo N; Arakawa K; Saku K J Am Coll Cardiol; 2003 Jun; 41(12):2197-204. PubMed ID: 12821247 [TBL] [Abstract][Full Text] [Related]
4. Angiotensin II type 1 receptor inhibition is associated with reduced tachyarrhythmia-induced ventricular interstitial fibrosis in a goat atrial fibrillation model. Chrysostomakis SI; Karalis IK; Simantirakis EN; Koutsopoulos AV; Mavrakis HE; Chlouverakis GI; Vardas PE Cardiovasc Drugs Ther; 2007 Oct; 21(5):357-65. PubMed ID: 17909956 [TBL] [Abstract][Full Text] [Related]
5. Repetitive 4-week periods of atrial electrical remodeling promote stability of atrial fibrillation: time course of a second factor involved in the self-perpetuation of atrial fibrillation. Todd DM; Fynn SP; Walden AP; Hobbs WJ; Arya S; Garratt CJ Circulation; 2004 Mar; 109(11):1434-9. PubMed ID: 15023893 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin II blockade, YKL-40 and maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation. Tveit A; Seljeflot I; Smith P; Arnesen H; Svendsen JH Immunobiology; 2013 Oct; 218(10):1256-60. PubMed ID: 23731775 [TBL] [Abstract][Full Text] [Related]
7. Chronic atrial dilation, electrical remodeling, and atrial fibrillation in the goat. Neuberger HR; Schotten U; Blaauw Y; Vollmann D; Eijsbouts S; van Hunnik A; Allessie M J Am Coll Cardiol; 2006 Feb; 47(3):644-53. PubMed ID: 16458150 [TBL] [Abstract][Full Text] [Related]
8. Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Ducharme A; Swedberg K; Pfeffer MA; Cohen-Solal A; Granger CB; Maggioni AP; Michelson EL; McMurray JJ; Olsson L; Rouleau JL; Young JB; Olofsson B; Puu M; Yusuf S; Am Heart J; 2006 Jul; 152(1):86-92. PubMed ID: 16838426 [TBL] [Abstract][Full Text] [Related]
9. Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) program. Ducharme A; Swedberg K; Pfeffer MA; Cohen-Solal A; Granger CB; Maggioni AP; Michelson EL; McMurray JJ; Olsson L; Rouleau JL; Young JB; Yusuf S Am Heart J; 2006 May; 151(5):985-91. PubMed ID: 16644318 [TBL] [Abstract][Full Text] [Related]
10. Electrophysiological effects of ranolazine in a goat model of lone atrial fibrillation. Opačić D; van Hunnik A; Zeemering S; Dhalla A; Belardinelli L; Schotten U; Verheule S Heart Rhythm; 2021 Apr; 18(4):615-622. PubMed ID: 33232809 [TBL] [Abstract][Full Text] [Related]
11. Sacubitril/valsartan attenuates atrial electrical and structural remodelling in a rabbit model of atrial fibrillation. Li LY; Lou Q; Liu GZ; Lv JC; Yun FX; Li TK; Yang W; Zhao HY; Zhang L; Bai N; Zhan CC; Yu J; Zang YX; Li WM Eur J Pharmacol; 2020 Aug; 881():173120. PubMed ID: 32325147 [TBL] [Abstract][Full Text] [Related]
12. Electrical remodeling and atrial dilation during atrial tachycardia are influenced by ventricular rate: role of developing tachycardiomyopathy. Schoonderwoerd BA; Van Gelder IC; van Veldhuisen DJ; Tieleman RG; Grandjean JG; Bel KJ; Allessie MA; Crijns HJ J Cardiovasc Electrophysiol; 2001 Dec; 12(12):1404-10. PubMed ID: 11797998 [TBL] [Abstract][Full Text] [Related]
13. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats. Paull JR; Widdop RE J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition. Okazaki H; Minamino T; Tsukamoto O; Kim J; Okada K; Myoishi M; Wakeno M; Takashima S; Mochizuki N; Kitakaze M Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335 [TBL] [Abstract][Full Text] [Related]
15. Repetitive electrical remodeling by paroxysms of atrial fibrillation in the goat: no cumulative effect on inducibility or stability of atrial fibrillation. Garratt CJ; Duytschaever M; Killian M; Dorland R; Mast F; Allessie MA J Cardiovasc Electrophysiol; 1999 Aug; 10(8):1101-8. PubMed ID: 10466491 [TBL] [Abstract][Full Text] [Related]
16. Blockade of angiotensin II improves hyperthyroid induced abnormal atrial electrophysiological properties. Xiao P; Gao C; Fan J; Du H; Long Y; Yin Y Regul Pept; 2011 Aug; 169(1-3):31-8. PubMed ID: 21545815 [TBL] [Abstract][Full Text] [Related]
17. Effect of candesartan and various inflammatory markers on maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation. Tveit A; Seljeflot I; Grundvold I; Abdelnoor M; Smith P; Arnesen H Am J Cardiol; 2007 Jun; 99(11):1544-8. PubMed ID: 17531578 [TBL] [Abstract][Full Text] [Related]
18. Inhibitors of the Na+/H+ exchanger cannot prevent atrial electrical remodeling in the goat. Blaauw Y; Beier N; van der Voort P; van Hunnik A; Schotten U; Allessie MA J Cardiovasc Electrophysiol; 2004 Apr; 15(4):440-6. PubMed ID: 15089994 [TBL] [Abstract][Full Text] [Related]
19. Effects of candesartan on electrical remodeling in the hearts of inherited dilated cardiomyopathy model mice. Odagiri F; Inoue H; Sugihara M; Suzuki T; Murayama T; Shioya T; Konishi M; Nakazato Y; Daida H; Sakurai T; Morimoto S; Kurebayashi N PLoS One; 2014; 9(7):e101838. PubMed ID: 25000405 [TBL] [Abstract][Full Text] [Related]
20. The effects of cilazapril and valsartan on the mRNA and protein expressions of atrial calpains and atrial structural remodeling in atrial fibrillation dogs. Li Y; Li WM; Gong YT; Li BX; Liu W; Han W; Dong D; Sheng L; Xue JY; Zhang L; Chu S; Yang BF Basic Res Cardiol; 2007 May; 102(3):245-56. PubMed ID: 17268887 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]